RECRUITINGPhase 4INTERVENTIONAL
Clinical Study of Endocardial Myocardial Biopsy
About This Trial
In this study, patients with endocardial myocardial biopsy were selected to observe the safety of the operation, and pathological examination was performed. If necessary, special tests such as viral examination, mass spectrometry and molecular biology were performed to confirm the diagnosis, and follow-up was performed.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients with no gender restriction, age 18-80 years old, receiving endocardial myocardial biopsy in the Second Affiliated Hospital of Zhejiang University School of Medicine;
- Patients with myocarditis, cardiomyopathy, heart failure and cardiac tumor of unknown clinical cause;
- Have the ability to understand the test, can cooperate with investigators.
Who Should NOT Join This Trial:
- Unable to understand or unwilling to fill in willing to sign a consent form forms or follow visitors.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients with no gender restriction, age 18-80 years old, receiving endocardial myocardial biopsy in the Second Affiliated Hospital of Zhejiang University School of Medicine;
* Patients with myocarditis, cardiomyopathy, heart failure and cardiac tumor of unknown clinical cause;
* Have the ability to understand the test, can cooperate with investigators.
Exclusion Criteria:
* Unable to understand or unwilling to fill in informed consent forms or follow visitors.
Treatments Being Tested
PROCEDURE
Endocardiomyocardial biopsy
Endocardiomyocardial biopsy
Locations (1)
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Hangzhou, Zhejiang, China